Last reviewed · How we verify
CASPOFUNGIN ACETATE
At a glance
| Generic name | CASPOFUNGIN ACETATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2001 |
Approved indications
Common side effects
- All Systems, Any Adverse Reaction
- Investigations
- General Disorders and Administration Site Conditions
- Gastrointestinal Disorders
- Respiratory, Thoracic and Mediastinal Disorders
- Skin and Subcutaneous Tissue Disorders
- Nervous System Disorders
- Metabolism and Nutrition Disorders
- Vascular Disorders
- Pyrexia
- Alanine Aminotransferase Increased
- Rash
Serious adverse events
- Hyperbilirubinemia
Key clinical trials
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. (PHASE3)
- Pharmacokinetics of Caspofungin in Burn Patients (PHASE2, PHASE3)
- PK/PD of Caspofungin in Children Severe Infection
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (PHASE3)
- A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole (PHASE3)
- Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study) (PHASE4)
- Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems (PHASE2)
- A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CASPOFUNGIN ACETATE CI brief — competitive landscape report
- CASPOFUNGIN ACETATE updates RSS · CI watch RSS